MEGHAN ELIZABETH GARSTKA M.D.
Prescription History 1154764421
Surgery - Surgical Oncology in Baltimore, MD
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MEGHAN ELIZABETH GARSTKA M.D., an active Surgical Oncology specialist practicing in Baltimore, MD. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 34 documented patient claims. Among these therapy options, the most frequently utilized medication is Oxycodone Hcl, which accounts for 34 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MD PrescribersVs. MD Avg |
|---|---|---|---|
| Oxycodone Hcl | 34 | $2.41▼ below MD avg | ▼ Less than typical |
About Oxycodone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A semisynthetic derivative of CODEINE. In 2024, this provider wrote 34 Medicare prescriptions for Oxycodone Hcl, about half the volume of the typical Maryland prescriber of this medication (75.4). Medicare paid an average of $2.41 per fill, versus $15.72 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MD prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MD average for this medication. 34 30-Day Fills standardized to 30-day supplies 107 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for MEGHAN ELIZABETH GARSTKA M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Surgical Oncology prescribing approach at this Baltimore, MD practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MD prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
